Literature DB >> 15891998

D2-40 and podoplanin are highly specific and sensitive immunohistochemical markers of epithelioid malignant mesothelioma.

Nelson G Ordóñez1.   

Abstract

Recent investigations have shown that podoplanin and the D2-40 monoclonal antibody, which reacts with an oncofetal antigen present in fetal germ cells, are highly reliable lymphatic endothelial markers. The observation that both of these markers are also expressed in normal and reactive mesothelial cells prompted an investigation into their potential value in the diagnosis of mesotheliomas. To determine whether podoplanin and D2-40 had any use in the diagnosis of these tumors, 40 mesotheliomas (29 epithelioid, 5 biphasic, and 6 sarcomatoid), 34 carcinomas of the lung (24 adenocarcinomas, 10 squamous carcinomas), 80 nonpulmonary adenocarcinomas (17 ovary, 10 breast, 10 colon, 10 kidney, 5 endometrium, 5 stomach, 5 pancreas, 5 prostate, 3 thyroid), 12 synovial sarcomas (6 biphasic and 6 monophasic), 5 angiosarcomas, and 2 adenomatoid tumors were immunostained with a monoclonal antibody to podoplanin and with the D2-40 antibody. Reactivity for both D2-40 and podoplanin was obtained in 25 (86%) of the 29 epithelioid mesotheliomas but in none of the carcinomas or sarcomatoid mesotheliomas. Positivity for D2-40 and podoplanin was also seen in the epithelioid components of 4 of 5 biphasic mesotheliomas and 4 of 6 synovial sarcomas, whereas the spindle cell components of these tumors were negative as were the monophasic synovial sarcomas. Two (40%) of the 5 angiosarcomas expressed these markers, thus confirming previous reports suggesting that some angiosarcomas may have lymphatic endothelial differentiation. Both of the adenomatoid tumors were also positive for D2-40 and podoplanin, a finding which provides further support for the mesothelial derivation of these tumors. It is concluded that, because of their high specificity and sensitivity for epithelioid mesotheliomas, D2-40 and podoplanin are very useful markers for the diagnosis of these tumors. When compared with the other markers that are currently available, in my opinion, they appear to be the best.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15891998     DOI: 10.1016/j.humpath.2005.01.019

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  54 in total

1.  Podoplanin expression in cancerous stroma induces lymphangiogenesis and predicts lymphatic spread and patient survival.

Authors:  Haruhisa Kitano; Shun-Ichiro Kageyama; Stephen M Hewitt; Ryuji Hayashi; Yoshinori Doki; Yoshitomo Ozaki; Shozo Fujino; Mikiko Takikita; Hajime Kubo; Junya Fukuoka
Journal:  Arch Pathol Lab Med       Date:  2010-10       Impact factor: 5.534

2.  Clear cell mesothelioma presenting as an incarcerated abdominal hernia.

Authors:  Nelson G Ordóñez
Journal:  Virchows Arch       Date:  2005-07-14       Impact factor: 4.064

3.  The contribution of B cells to renal interstitial inflammation.

Authors:  Florian Heller; Maja T Lindenmeyer; Clemens D Cohen; Ulrike Brandt; Dan Draganovici; Michael Fischereder; Matthias Kretzler; Hans-Joachim Anders; Thomas Sitter; Isabella Mosberger; Dontscho Kerjaschki; Heinz Regele; Detlef Schlöndorff; Stephan Segerer
Journal:  Am J Pathol       Date:  2007-02       Impact factor: 4.307

4.  Laparoscopy-assisted distal gastrectomy with laparoscopic sentinel lymph node biopsy after endoscopic mucosal resection for early gastric cancer.

Authors:  Hitoshi Tonouchi; Yasuhiko Mohri; Minako Kobayashi; Kouji Tanaka; Masaki Ohi; Masato Kusunoki
Journal:  Surg Endosc       Date:  2007-02-03       Impact factor: 4.584

5.  Pathology of mesothelioma.

Authors:  Kouki Inai
Journal:  Environ Health Prev Med       Date:  2008-02-28       Impact factor: 3.674

Review 6.  Newer developments in immunohistology.

Authors:  A S-Y Leong; T Y-M Leong
Journal:  J Clin Pathol       Date:  2006-11       Impact factor: 3.411

7.  Immunohistochemical examination on the distribution of cells expressed lymphatic endothelial marker podoplanin and LYVE-1 in the mouse tongue tissue.

Authors:  Yuya Noda; Ikuko Amano; Minoru Hata; Hiroshi Kojima; Yoshihiko Sawa
Journal:  Acta Histochem Cytochem       Date:  2010-04-07       Impact factor: 1.938

8.  Immunoelectron microscopic study of podoplanin localization in mouse salivary gland myoepithelium.

Authors:  Minoru Hata; Ikuko Amano; Eichi Tsuruga; Hiroshi Kojima; Yoshihiko Sawa
Journal:  Acta Histochem Cytochem       Date:  2010-04-21       Impact factor: 1.938

9.  Podoplanin in cancer cells is experimentally able to attenuate prolymphangiogenic and lymphogenous metastatic potentials of lung squamoid cancer cells.

Authors:  Hanako Suzuki; Mitsuho Onimaru; Yoshikazu Yonemitsu; Yoshihiko Maehara; Seiji Nakamura; Katsuo Sueishi
Journal:  Mol Cancer       Date:  2010-10-31       Impact factor: 27.401

10.  Immunohistochemical examination for the distribution of podoplanin-expressing cells in developing mouse molar tooth germs.

Authors:  Yuri Imaizumi; Ikuko Amano; Eichi Tsuruga; Hiroshi Kojima; Yoshihiko Sawa
Journal:  Acta Histochem Cytochem       Date:  2010-10-15       Impact factor: 1.938

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.